全文获取类型
收费全文 | 2913517篇 |
免费 | 244246篇 |
国内免费 | 12940篇 |
专业分类
耳鼻咽喉 | 40037篇 |
儿科学 | 92184篇 |
妇产科学 | 73361篇 |
基础医学 | 479716篇 |
口腔科学 | 77844篇 |
临床医学 | 262194篇 |
内科学 | 496652篇 |
皮肤病学 | 82765篇 |
神经病学 | 250574篇 |
特种医学 | 113589篇 |
外国民族医学 | 92篇 |
外科学 | 457296篇 |
综合类 | 88597篇 |
现状与发展 | 23篇 |
一般理论 | 2100篇 |
预防医学 | 249760篇 |
眼科学 | 66320篇 |
药学 | 196678篇 |
22篇 | |
中国医学 | 8556篇 |
肿瘤学 | 132343篇 |
出版年
2022年 | 22961篇 |
2021年 | 54782篇 |
2020年 | 35009篇 |
2019年 | 58133篇 |
2018年 | 70260篇 |
2017年 | 53438篇 |
2016年 | 58709篇 |
2015年 | 73406篇 |
2014年 | 107484篇 |
2013年 | 172660篇 |
2012年 | 76304篇 |
2011年 | 74433篇 |
2010年 | 112783篇 |
2009年 | 118162篇 |
2008年 | 62013篇 |
2007年 | 62900篇 |
2006年 | 74435篇 |
2005年 | 70067篇 |
2004年 | 72380篇 |
2003年 | 63582篇 |
2002年 | 53806篇 |
2001年 | 74072篇 |
2000年 | 66158篇 |
1999年 | 71664篇 |
1998年 | 62007篇 |
1997年 | 60481篇 |
1996年 | 58264篇 |
1995年 | 53746篇 |
1994年 | 47891篇 |
1993年 | 44835篇 |
1992年 | 47924篇 |
1991年 | 46287篇 |
1990年 | 43907篇 |
1989年 | 43889篇 |
1988年 | 40772篇 |
1987年 | 39942篇 |
1986年 | 37997篇 |
1985年 | 38879篇 |
1984年 | 38546篇 |
1983年 | 36090篇 |
1982年 | 38126篇 |
1981年 | 36374篇 |
1980年 | 34370篇 |
1979年 | 30933篇 |
1978年 | 29765篇 |
1977年 | 27770篇 |
1976年 | 25520篇 |
1975年 | 24177篇 |
1974年 | 23897篇 |
1973年 | 22666篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
981.
C G Arruda J M Aldrighi L A Bortolotto I N Alecrin J A F Ramires 《Gynecological endocrinology》2006,22(10):557-563
BACKGROUND: Arterial hypertension and postmenopausal reduction of estrogen levels may be involved in modifications of the stiffness of large arteries. OBJECTIVES: To evaluate the pulse-wave velocity (PWV) and indirectly the arterial stiffness in hypertensive postmenopausal women submitted to hormone therapy with estradiol alone or combined with norethisterone acetate. SUBJECTS: Forty-five hypertensive postmenopausal women were double-blindly, randomly assigned to three arms of treatment: placebo (group I); estradiol 2 mg/day (group II); or estradiol 2 mg/day and norethisterone acetate 1 mg/day (group III). METHODS: Arterial stiffness was assessed from PWV measurements of the common carotid and femoral arteries (CF-PWV) and the common carotid and radial arteries (CR-PWV) obtained using the automatic Complior(R) device, taken at baseline and after 12 weeks of treatment. RESULTS: After the 12-week treatment, values of CF-PWV and CR-PWV were not significantly different (p = 0.910 and p = 0.736, respectively) among the groups. Systolic blood pressure showed a positive correlation with CF-PWV in groups II and III (p = 0.02 and p < 0.001, respectively). CONCLUSIONS: PWV and arterial stiffness in postmenopausal hypertensive women did not reduce over a 12-week treatment with estradiol alone compared with the same period of treatment with estradiol combined with norethisterone acetate. 相似文献
982.
The aim of our study was to determine the incidence, timing, and severity of vaginal stenosis in patients with carcinoma of the cervix who had received pelvic and/or vaginal radiotherapy as part of their treatment. We also sought to determine if there were any predisposing factors for the development of stenosis. A retrospective chart review was undertaken for all the patients diagnosed with carcinoma of the cervix between January 1, 1990, and December 31, 2000 and treated with pelvic and/or vaginal radiation at Westmead Hospital. Since January 1, 1990, data regarding vaginal stenosis has been prospectively recorded on all the patients. Data collected included patient demographics, stage of disease, treatments administered, and incidence, timing, and severity of vaginal stenosis. One hundred and eighty-eight patients were treated. Mean age was 58.6 years. Thirteen percent of patients had stage IB disease, 45% had stage II disease, 39.5% had stage III disease, and 1.5% had stage IV disease. One hundred and seventy-nine patients returned for follow-up, and data regarding vaginal toxicity were available in 98%. Twenty-seven percent had grade 1 toxicity (partial stenosis or shortening but not complete occlusion), and 11% had grade 2 (complete occlusion). Stenosis of any grade was noted at a mean of 9.6 months and median of 7.5 months (range, 26 days-5.6 years) from completion of treatment. The only prognostic factor associated with increased risk of stenosis was age greater than 50 years (odds ratio 2.26). Vaginal stenosis is a common complication of pelvic and vaginal radiotherapy, occurring in 38% of patients. Stenosis occurs most often in the first year after treatment. Patients over the age of 50 are most at risk. 相似文献
983.
Jonathan Larkin Anne Bost John I Glass Seng-Lai Tan 《Journal of interferon & cytokine research》2006,26(12):854-865
Hepatitis C virus (HCV)-specific impairments in host immunity have been described at multiple levels of the innate and adaptive response, which may lead to viral persistence in the majority of infections. Understanding of HCV-associated immune defects could lead to novel therapeutic advances. Natural killer (NK) cells, the major effector cells of the innate immune system, are functionally impaired in chronic HCV infection. It has been suggested that this phenotype is a result of virus-specific defects in antigen-presenting cells (APCs) that regulate NK cell activity, as normal NK function is restored when they are stimulated ex vivo. In this study, we used human NK cell cytotoxicity assays to evaluate the activation-induced effects of NK cells on the HCV replicon-containing hepatic cells. We found that cytokine-activated NK cells were capable of inducing an HCV-associated, perforin/granzyme-dependent lysis of human hepatoma cells and that this required direct cellular contact and was independent of MHC class I expression levels. In contrast, on removal of cytokine stimulation, NK cells failed to exert any direct cytolytic effect on replicon targets. These findings suggest an important underlying mechanism by which NK cells control HCV infection and, with appropriate understanding of HCV-associated immune defects, could lead to novel therapeutic advances. 相似文献
984.
985.
986.
分子靶向药物bevacizumab是针对血管内皮生长因子(VEGF)的重组人源化单克隆抗体,在多种恶性肿瘤的治疗中显示了临床效果。现就bevacizumab的作用机制及其在乳腺癌治疗中的临床研究进展作一综述。 相似文献
987.
988.
989.
990.
Abstract: Background: Identification of risk drinking in expectant fathers may be helpful as an important part of efforts to minimize maternal alcohol use, and as an opportunity to inform them about a problematic practice during a critical developmental stage for the couple. The purpose of this study was to evaluate the T‐ACE screening questionnaire, which asks about t olerance to alcohol, being a nnoyed by other's comments about drinking, attempts to c ut down, and having a drink first thing in the morning (“ e ye‐opener”), in the male partners of pregnant women who themselves were T‐ACE positive. Methods: Two hundred fifty‐four male partners were asked to complete the T‐ACE embedded in a health survey, the Alcohol Use Disorders Identification Test (AUDIT), and other questions about their alcohol use in the past 30 days when their pregnant partners had a median gestation of 11.5 weeks (T1). After delivery, male partners again completed the T‐ACE and quantity‐frequency questions (T2). The predictive ability of the T‐ACE and AUDIT was compared, using risk drinking (>4 drinks/day or >14 drinks/week) as the criterion standard. Results: A substantial minority of male partners had risk drinking, 31 percent at T1 and 25 percent at T2. Although the AUDIT was better than the T‐ACE as an independent predictor of risk drinking, the latter was most accurate when the tolerance threshold exceeded 2 drinks, the same established for pregnant women. The sensitivity (T1 = 84.6%, T2 = 82.8%) and specificity (T1 = 43.8%, T2 = 51.1%) of the T‐ACE at this threshold compared favorably with those of the AUDIT at the standard cut point of 8. Conclusions: The T‐ACE may be a practical way for clinicians to identify risk drinking in both pregnant women and expectant fathers. (BIRTH 33:2 June 2006) 相似文献